We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
MAPK14 / p38 (C-Terminus) antibody
Mitogen-activated protein kinase 14, MAP kinase 14, MAPK 14
Cytokine suppressive anti-inflammatory drug-binding protein, CSAID-binding protein, CSBP
MAP kinase MXI2
MAX-interacting protein 2
Mitogen-activated protein kinase p38 alpha, MAP kinase p38 alpha
Stress-activated protein kinase 2a, SAPK2a
Cytokine suppressive anti-inflammatory drug-binding protein, CSAID-binding protein, CSBP
MAP kinase MXI2
MAX-interacting protein 2
Mitogen-activated protein kinase p38 alpha, MAP kinase p38 alpha
Stress-activated protein kinase 2a, SAPK2a
Out of stock
Ref
00019388
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets.
ID Covalab | pab72115 |
---|---|
Product type | Primary antibodies |
Clonality | Polyclonal antibody |
Isotype | IgG |
Raised in | Rabbit |
Immunogen | Synthetic peptide from C-Terminal part of mouse MAPK14 / p38. |
Activity cross reaction | Reacts with the C-terminus part of mouse MAPK14 / p38. Cross reacts with human and rat protein. |
Species | Hu, Ms, Rat |
Labelling | None |
Form | Antigen affinity purified |
Preservative | NaN3 0.09% |
Storage instructions | +4°C, avoid freezing |
Target | MAPK14 / p38 |
Uniprot ID | Q16539 |
Gene ID | 1432 |
Applications | IHC - P, WB |
Working dilutions | Optimal dilutions should be determined by the end user. The following are guidelines only: IHC-P (1:100) |
Write Your Own Review